Bluejay Diagnostics, Inc.
BJDX- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001704287
In the last 90 days, Bluejay Diagnostics, Inc. insiders filed 1 open-market purchase and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $259.3K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Bluejay Diagnostics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- +2 vs. Q3 2022
- Shares held
- 302.5K
- +112.5K (+59.2%) vs. Q3 2022
- Total value
- $109.0K
- −$37.0K (−25.3%) vs. Q3 2022
- New holders
- 5
- 2 more added
- Sold out
- 3
- 2 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BJDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 8 | $259.3K |
| Q1 2026 | 6 | $108.2K |
| Q4 2025 | 9 | $112.3K |
| Q3 2025 | 4 | $142.7K |
| Q2 2025 | 5 | $170.3K |
| Q1 2025 | 4 | $9.61K |
| Q4 2024 | 3 | $12.2K |
| Q3 2024 | 13 | $129.0K |
| Q2 2024 | 5 | $118.6K |
| Q1 2024 | 9 | $344.7K |
| Q4 2023 | 7 | $243.4K |
| Q3 2023 | 6 | $99.8K |
| Q2 2023 | 11 | $47.4K |
| Q1 2023 | 10 | $55.7K |
| Q4 2022 | 14 | $109.0K |
| Q3 2022 | 12 | $146.0K |
| Q2 2022 | 12 | $258.0K |
| Q1 2022 | 8 | $98.0K |
| Q4 2021 | 9 | $267.0K |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Bluejay Diagnostics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 11 | $4 | 0.00% | +11 | New |
| Wells Fargo & Company | 69 | $26 | 0.00% | +2+3.0% | Added |
| UBS Group AG | 10,061 | $3.82K | 0.00% | −3,364−25.1% | Reduced |
| Tower Research Capital LLC (TRC) | 10,211 | $4.00K | 0.00% | −1,346−11.6% | Reduced |
| Northern Trust Corp | 11,699 | $4.44K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 14,174 | $4.76K | 0.00% | +14,174 | New |
| StoneX Group Inc. | 15,000 | $5.70K | 0.00% | +15,000 | New |
| Vanguard Group Inc | 15,899 | $6.04K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 17,837 | $6.78K | 0.00% | +17,837 | New |
| Sabby Management, LLC | 26,091 | $9.91K | 0.03% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 30,220 | $10.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 65,791 | $25.0K | 0.00% | +16,191+32.6% | Added |
| Susquehanna International Group, LLP | 84,890 | $28.5K | 0.00% | +84,890 | New |
| Millennium Management LLC | 0 | $0 | 0.00% | −15,882−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,016−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |